The global tuberculosis (TB) epidemic, caused by the pathogen Mycobacterium tuberculosis (Mtb), is aggravated by the emergence of extremely drug resistant and multi-drug resistant strains. The present situation necessitates the identification and characterization of new drug targets. The histidine (His) biosynthetic pathway ( Figure) , which converts 5-phosphoribosyl-1-pyrophosphate to histidine in ten enzymatic steps, is essential for Mtb growth but is absent in mammals, thus making it an attractive anti-TB drug target. The enzymes of the His pathway are largely conserved across the bacteria, fungi and lower eukaryotes that synthesize histidine de novo with some differences in a few catalytic steps; particularly the fifth, sixth and eighth steps. The determination of the Mtb genome sequence provided a map of the genes involved in its His pathway. However, it was unclear which particular enzyme catalyzes the eighth step-the dephosphorylation of Histidinol phosphate(HOLP) to Histidinol(HOL). In this study, employing bioinformatic approaches, the Histidinol phosphate phosphatase of Mtb was identified.
